Hyderabad: Life sciences innovation and transformation company Agilisium said on Tuesday it plans to shift its Asia headquarters to Hyderabad from Chennai as part of an expansion aimed at tapping Telangana ’s pharmaceutical, biotechnology and innovation ecosystem.
Agilisium, which entered life sciences in 2018, expects to close 2026 with revenue of $72 million to $75 million and cross $100 million in annual life sciences revenue in 2027. You Can Also Check: Gold Rate in Hyderabad | Silver Rate in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad | Hyderabad AQI | Weather in Hyderabad | Petrol Price in Hyderabad | Diesel Price in Hyderabad | CNG Price in Hyderabad | LPG Price in Hyderabad Stay updated with the latest Hyderabad news.
Agilisium founder & CEO Raj Babu said Hyderabad’s ecosystem, supported by Telangana’s Life Sciences leadership and platforms such as BioAsia, positions the city for the next phase of global industry innovation. He said Agilisium aims to move beyond the traditional IT services model by combining scientific expertise, domain knowledge, advanced AI and proprietary intellectual property. Agilisium COO and chief AI & innovation officer Arun Kumar said the Hyderabad move would strengthen investments in talent, AI platforms and labs.
Its work spans research, drug discovery, clinical development, manufacturing and commercial operations. Download the TOI App.
Agilisium is targeting $500 million in revenue and a workforce of about 5,000 specialised professionals over the next five to seven years. Of this, it plans to hire 2,000-2,500 in Hyderabad alone over the next five years.
The company said Hyderabad will join Chennai and Pune as a core operating centre and support its plan to build an India-originated global life sciences enterprise.